‌

US Patent 10302663 Method of assessing pancreatic beta-cell function

Patent 10302663 was granted and assigned to Metabolon on May, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Metabolon

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10302663

Patent Inventor Names

Walter Gall0

Kay A. Lawton0

Date of Patent

May 28, 2019

Patent Application Number

14344655

Date Filed

September 11, 2012

Patent Primary Examiner

‌

Jeremy C Flinders

Patent abstract

Biomarkers relating to pancreatic Beta-cell function, pancreatic Beta-cell glucose sensitivity, insulin resistance, and/or pancreatic Beta-cell-related disorders are provided. Methods based on the same biomarkers are also provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10302663 Method of assessing pancreatic beta-cell function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API